Press Releases March 29, 2026 08:00 PM

Iperionx – Change of Directors and Officers Ownership

IperionX Announces Changes in Directors and Officers Ownership with SEC and ASX Filings

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
IPX

IperionX Limited has reported recent changes in the ownership stakes of its directors and officers, filing the information with both the U.S. Securities and Exchange Commission and the Australian Securities Exchange. Key executives, including the CEO and President, have acquired additional shares and American Depositary Shares, reflecting internal ownership adjustments.

Iperionx – Change of Directors and Officers Ownership
IPX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Multiple directors and officers of IperionX acquired additional shares and ADSs, indicating potential confidence in the company.
  • The ownership changes have been officially filed with regulatory bodies in both the U.S. and Australia, ensuring transparency.
  • Executives involved include the CEO Anastasios Arima and President Toby Symonds, among others.
  • The filings impact sectors related to advanced materials and energy storage, as IperionX operates in specialty metals for battery production.

SOUTH BOSTON, Va., March 30, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) has lodged filings with the Securities and Exchange Commission and the Australian Securities Exchange relating to changes in Directors’ and Officer’s ownership in IperionX.

A summary of the changes can be found below.

Director / OfficerNo. of Securities AcquiredValue / ConsiderationValue / Consideration (US$)1Anastasios ARIMA467,000 Shares
12,800 ADSsA$1,493,480.25(Shares) US$299,643.64 (ADSs)US$1,331,787.84Todd HANNIGAN225,225 SharesA$720,917.30US$498,225.95R. Tony TRIPENY4,187 ADSsUS$99,463.67US$99,463.67Toby SYMONDS11,000 ADSsUS$262,552.40US$262,552.40

1. Converted from A$ to US$ using the Reserve Bank of Australia’s A$:US$ exchange rate on May 27, 2026 of 0.6911.

Contacts

Anastasios (Taso) Arima, Founder and CEO
Toby Symonds, President
Dominic Allen, Chief Commercial Officer

Investors: [email protected]
Media: [email protected]

+1 980 237 8900
www.iperionx.com


Risks

  • Stock ownership changes do not inherently indicate future operational or financial performance changes, creating uncertainty for investors.
  • Exchange rate fluctuations between Australian dollars and U.S. dollars can affect the valuation of acquired shares and market perception.
  • Market reaction to insider ownership changes can vary and may not lead to immediate stock price movement, maintaining potential volatility.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026